全文获取类型
收费全文 | 1229篇 |
免费 | 57篇 |
专业分类
1286篇 |
出版年
2023年 | 4篇 |
2022年 | 14篇 |
2021年 | 22篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 14篇 |
2017年 | 11篇 |
2016年 | 32篇 |
2015年 | 46篇 |
2014年 | 56篇 |
2013年 | 100篇 |
2012年 | 94篇 |
2011年 | 81篇 |
2010年 | 53篇 |
2009年 | 60篇 |
2008年 | 62篇 |
2007年 | 52篇 |
2006年 | 75篇 |
2005年 | 72篇 |
2004年 | 63篇 |
2003年 | 67篇 |
2002年 | 45篇 |
2001年 | 10篇 |
2000年 | 6篇 |
1999年 | 15篇 |
1998年 | 9篇 |
1997年 | 18篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 5篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 6篇 |
1985年 | 5篇 |
1984年 | 17篇 |
1982年 | 7篇 |
1980年 | 3篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1973年 | 3篇 |
1967年 | 3篇 |
1965年 | 5篇 |
1964年 | 3篇 |
1917年 | 3篇 |
1916年 | 3篇 |
1915年 | 3篇 |
排序方式: 共有1286条查询结果,搜索用时 8 毫秒
911.
The synergism of stem cell biology and biomaterial technology promises to have a profound impact on stem-cell-based clinical applications for tissue regeneration. Biomaterials development is rapidly advancing to display properties that, in a precise and physiological fashion, could drive stem-cell fate both in vitro and in vivo. Thus, the design of novel materials is trying to recapitulate the molecular events involved in the production, clearance and interaction of molecules within tissue in pathologic conditions and regeneration of tissue/organs. In this review we will report on the challenges behind translating stem cell biology and biomaterial innovations into novel clinical therapeutic applications for tissue and organ replacements (graphical abstract). 相似文献
912.
Loguercio C Andreone P Brisc C Brisc MC Bugianesi E Chiaramonte M Cursaro C Danila M de Sio I Floreani A Freni MA Grieco A Groppo M Lazzari R Lobello S Lorefice E Margotti M Miele L Milani S Okolicsanyi L Palasciano G Portincasa P Saltarelli P Smedile A Somalvico F Spadaro A Sporea I Sorrentino P Vecchione R Tuccillo C Del Vecchio Blanco C Federico A 《Free radical biology & medicine》2012,52(9):1658-1665
The only currently recommended treatment for nonalcoholic fatty liver disease (NAFLD) is lifestyle modification. Preliminary studies of silybin showed beneficial effects on liver function. Realsil (RA) comprises the silybin phytosome complex (silybin plus phosphatidylcholine) coformulated with vitamin E. We report on a multicenter, phase III, double-blind clinical trial to assess RA in patients with histologically documented NAFLD. Patients were randomized 1:1 to RA or placebo (P) orally twice daily for 12 months. Prespecified primary outcomes were improvement over time in clinical condition, normalization of liver enzyme plasma levels, and improvement of ultrasonographic liver steatosis, homeostatic model assessment (HOMA), and quality of life. Secondary outcomes were improvement in liver histologic score and/or decrease in NAFLD score without worsening of fibrosis and plasma changes in cytokines, ferritin, and liver fibrosis markers. We treated 179 patients with NAFLD; 36 were also HCV positive. Forty-one patients were prematurely withdrawn and 138 patients analyzed per protocol (69 per group). Baseline patient characteristics were generally well balanced between groups, except for steatosis, portal infiltration, and fibrosis. Adverse events (AEs) were generally transient and included diarrhea, dysgeusia, and pruritus; no serious AEs were recorded. Patients receiving RA but not P showed significant improvements in liver enzyme plasma levels, HOMA, and liver histology. Body mass index normalized in 15% of RA patients (2.1% with P). HCV-positive patients in the RA but not the P group showed improvements in fibrogenesis markers. This is the first study to systematically assess silybin in NAFLD patients. Treatment with RA but not P for 12 months was associated with improvement in liver enzymes, insulin resistance, and liver histology, without increases in body weight. These findings warrant further investigation. 相似文献
913.
914.
The objective of this study was to investigate microbial species diversity and strain complexity of the cultivable non starter lactic acid bacteria (NSLAB) occurring in 31 ripened Parmigiano Reggiano (PR) cheeses. Dereplication of 127 lactobacilli isolates by (GTG)(5)-PCR fingerprinting yielded a total of 51 genotypes. Phylogenetic relatedness of all the genotypes with known Lactobacillus species was determined by a novel combined amplified 16S rDNA restriction analysis (16S-ARDRA), species-specific PCR assays and 16S rRNA gene sequencing. The species Lactobacillus rhamnosus and Lactobacillus paracasei comprise the largest portions of the cultivable NSLAB community in PR cheese, with an inter-individual diversity ranging from one to four dominant genotypes per sample. Lactobacillus casei, Lactobacillus harbinensis and Lactobacillus fermentum species were also detected at low frequency. The data showed differences in cultivable NSLAB population, with an overall decrease in diversity and complexity from early to advanced stages of ripening. Finally the de-replicated collection of genotypes resulting from this work is the bases for further functional screening. 相似文献
915.
Caliendo G Perissutti E Santagada V Fiorino F Severino B di Villa Bianca Rd Lippolis L Pinto A Sorrentino R 《Bioorganic & medicinal chemistry》2002,10(8):2663-2669
As part of a search for new potassium channel openers, the synthesis and vasorelaxant activity of new 1,4-benzoxazine derivatives derived from transformation of the benzopyran skeleton of cromakalim were described. Several new 1,4-benzoxazine derivatives were provided with significant vasorelaxant activity with an overall pharmacological behavior similar to CRK (1f, 1i, 2d, 2e, 2f and 2i). 相似文献
916.
Marie-José C. van Lierop Wynand Alkema Anke J. Laskewitz Rein Dijkema Hans M. van der Maaden Martin J. Smit Ralf Plate Paolo G. M. Conti Christan G. J. M. Jans C. Marco Timmers Constant A. A. van Boeckel Scott J. Lusher Ross McGuire Rene C. van Schaik Jacob de Vlieg Ruben L. Smeets Claudia L. Hofstra Annemieke M. H. Boots Marcel van Duin Benno A. Ingelse Willem G. E. J. Schoonen Aldo Grefhorst Theo H. van Dijk Folkert Kuipers Wim H. A. Dokter 《PloS one》2012,7(11)
Glucocorticoids (GCs) such as prednisolone are potent immunosuppressive drugs but suffer from severe adverse effects, including the induction of insulin resistance. Therefore, development of so-called Selective Glucocorticoid Receptor Modulators (SGRM) is highly desirable. Here we describe a non-steroidal Glucocorticoid Receptor (GR)-selective compound (Org 214007-0) with a binding affinity to GR similar to that of prednisolone. Structural modelling of the GR-Org 214007-0 binding site shows disturbance of the loop between helix 11 and helix 12 of GR, confirmed by partial recruitment of the TIF2-3 peptide. Using various cell lines and primary human cells, we show here that Org 214007-0 acts as a partial GC agonist, since it repressed inflammatory genes and was less effective in induction of metabolic genes. More importantly, in vivo studies in mice indicated that Org 214007-0 retained full efficacy in acute inflammation models as well as in a chronic collagen-induced arthritis (CIA) model. Gene expression profiling of muscle tissue derived from arthritic mice showed a partial activity of Org 214007-0 at an equi-efficacious dosage of prednisolone, with an increased ratio in repression versus induction of genes. Finally, in mice Org 214007-0 did not induce elevated fasting glucose nor the shift in glucose/glycogen balance in the liver seen with an equi-efficacious dose of prednisolone. All together, our data demonstrate that Org 214007-0 is a novel SGRMs with an improved therapeutic index compared to prednisolone. This class of SGRMs can contribute to effective anti-inflammatory therapy with a lower risk for metabolic side effects. 相似文献
917.
918.
919.
Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice 总被引:3,自引:0,他引:3
Pearson T Markees TG Serreze DV Pierce MA Marron MP Wicker LS Peterson LB Shultz LD Mordes JP Rossini AA Greiner DL 《Journal of immunology (Baltimore, Md. : 1950)》2003,171(1):185-195
Curing type 1 diabetes by islet transplantation requires overcoming both allorejection and recurrent autoimmunity. This has been achieved with systemic immunosuppression, but tolerance induction would be preferable. Most islet allotransplant tolerance induction protocols have been tested in nonobese diabetic (NOD) mice, and most have failed. Failure has been attributed to the underlying autoimmunity, assuming that autoimmunity and resistance to transplantation tolerance have a common basis. Out of concern that NOD biology could be misleading in this regard, we tested the hypothesis that autoimmunity and resistance to transplantation tolerance in NOD mice are distinct phenotypes. Unexpectedly, we observed that (NOD x C57BL/6)F(1) mice, which have no diabetes, nonetheless resist prolongation of skin allografts by costimulation blockade. Further analyses revealed that the F(1) mice shared the dendritic cell maturation defects and abnormal CD4(+) T cell responses of the NOD but had lost its defects in macrophage maturation and NK cell activity. We conclude that resistance to allograft tolerance induction in the NOD mouse is not a direct consequence of overt autoimmunity and that autoimmunity and resistance to costimulation blockade-induced transplantation tolerance phenotypes in NOD mice can be dissociated genetically. The outcomes of tolerance induction protocols tested in NOD mice may not accurately predict outcomes in human subjects. 相似文献
920.